Shares of AbbVie plummeted Monday after the company said its schizophrenia drug Emraclidine missed key goals in a pair of trials.

Some people who took a new schizophrenia drug for one year improved with only a few side effects, but many dropped out of the research.

Abstracts and additional details can be found at the CNS Summit 2024 website.

ktalnews.com ...

What early voting trends reveal about state of 2024 race Scientists find the reason why people with schizophrenia hear voices — and maybe how to stop them Check out the new AI features coming to ...

AbbVie Inc (NYSE: ABBV) saw its stock fall nearly 13% after reporting disappointing mid-stage trial results for emraclidine, ...

Dylan Thomas, 24, searched “anatomy of the neck” just before allegedly ambushing his unsuspecting roommate and friend, William Bush, 23, who was planning on moving in with a girlfriend.

The case of Marilyn Cote’s fake practice, which promised to cure depression “in six days," exemplifies the issue of medical imposters in Mexico.

The lawyer, who used fake IDs and fabricated degrees to prescribe psychiatric drugs, posed as the ‘best specialist in mental ...

County facilities reported their highest detainee death count in decades in 2022, including multiple suicides that reveal ...

Activists and community members criticized the presidential candidates’ deprioritization of criminal justice reform at ...